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Abstract: Glucose oxidase (GOx) is an important industrial enzyme that can be optimized for
specific applications by mutagenesis and activity-based screening. To increase the efficiency of this
approach, we have developed a new ultrahigh-throughput screening platform based on a microfluidic
lab-on-chip device that allows the sorting of GOx mutants from a saturation mutagenesis library
expressed on the surface of yeast cells. GOx activity was measured by monitoring the fluorescence
of water microdroplets dispersed in perfluorinated oil. The signal was generated via a series of
coupled enzyme reactions leading to the formation of fluorescein. Using this new method, we
were able to enrich the yeast cell population by more than 35-fold for GOx mutants with higher
than wild-type activity after two rounds of sorting, almost double the efficiency of our previously
described flow cytometry platform. We identified and characterized novel GOx mutants, the most
promising of which (M6) contained a combination of six point mutations that increased the catalytic
constant kcat by 2.1-fold compared to wild-type GOx and by 1.4-fold compared to a parental GOx
variant. The new microfluidic platform for GOx was therefore more sensitive than flow cytometry
and supports comprehensive screens of gene libraries containing multiple mutations per gene.
Keywords: fluorescent label; sorting; protein engineering; enzyme optimization
1. Introduction
Enzymes are widely used for industrial processes, but natural enzymes tend to be incompatible
with harsh process conditions and must be optimized using molecular evolution methods to improve
properties such as stability or substrate preference [1,2]. This protein engineering approach involves
the generation of gene libraries containing variants of the original enzyme sequence, followed by
screening to select enzyme variants with desirable characteristics [1]. The greater the diversity in the
library, the more likely a better-performing mutant will be identified. However, the link between
the mutant phenotype and genotype must be preserved during screening in order to recover the
corresponding gene sequence for enzyme expression [3]. The link is easily preserved by screening
in microtiter plates if each variant is restricted to a single well, but this approach limits the library
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complexity to a maximum of 104 variants per screening round, increasing the likelihood that the most
active or stable enzyme variants will be overlooked [4]. Higher-throughput methods are therefore
needed to screen libraries containing 106–1010 variants, which is the scale required to capture enzyme
structural diversity in its entirety.
Fluorescence-activated cell sorting (FACS) has been used with success to screen horseradish
peroxidase (HRP) mutants for modified enantioselectivity [5]. The enzyme was expressed on the
surface of yeast cells, where it converted a covalently-bound substrate into a fluorescent product.
This approach becomes challenging with more complex reactions due to the potential for cross-labeling
between cells expressing different enzyme variants [6]. Most FACS screening protocols therefore
involve reactions performed in double (water-oil-water) emulsions [7], which provide individual
compartments to preserve the link between enzyme activity and the corresponding gene. However,
the size of the emulsion droplets is difficult to control, leading to differences in fluorescence levels due
to the presence of more substrate in the larger droplets, and false positives may occur if multiple inner
droplets with different enzyme variants are encapsulated together [8]. FACS sorting for the directed
evolution of enzymes could be improved greatly if there were a simple way to produce monodisperse
double emulsions.
Microfluidics offers a potential solution because this state-of-the-art technology significantly
reduces fluid volumes, allowing the production of monodisperse emulsion droplets whose size and
composition can be controlled [8]. Microfluidic lab-on-chip (LOC) devices are attractive due to their low
cost, fast reaction times, and high sensitivity [9]. Such devices are therefore found in diverse applications
such as next-generation sequencing [10], environmental studies [11], drug discovery, organ-on-a-chip
system development [12], and cancer diagnostics [13]. Microfluidics is particularly suitable for
cell-based assays [14] and single-cell analysis [15], facilitating the development of high-throughput
screening systems [16].
Another challenge associated with enzyme screening is that high enzyme concentrations within an
emulsion droplet can rapidly exhaust the substrate, taking the assay to plateau in a matter of seconds
or minutes. Once the assay has plateaued, any correlation between enzyme activity and fluorescence
intensity is lost and there will be no measurable difference between droplets containing enzyme
variants with high and low activity. This problem is exacerbated by FACS because the timeframe
between emulsion preparation and screening/sorting is difficult to control [17]. The use of competitive
enzyme reactions with two substrates can partially address this problem, as demonstrated in a screen
for HRP variants [18], but this solution is not applicable for all assays. However, the problem is
minimized by microfluidic LOC technology because the timing of cell encapsulation, mixing with
substrate, signal measurement, and sorting can be precisely controlled. This allows an enzymatic
reaction to be characterized after time delays of milliseconds, seconds or minutes [8,19]. Furthermore,
the smaller reaction volumes and use of disposable microchips significantly reduce the cost of the
process [9].
Given these combined advantages, the high-throughput screening of enzyme libraries by droplet
microfluidics should allow the top 5% most active enzyme variants to be sorted from a library
containing only active mutants. We applied this approach to optimize the properties of glucose
oxidase (GOx), a flavoprotein monooxygenase (β-d-glucose: oxygen 1-oxidoreductase, EC 1.1.3.4) that
catalyzes the oxidation of β-d-glucose to glucono-δ-lactone, which in turn spontaneously hydrolyses
to form gluconic acid. GOx is naturally secreted by Aspergillus niger as a glycosylated homodimer
with a molecular weight of 160 kDa [20]. The enzyme has many commercial applications [21] in the
food [22–24], pharmaceutical [21,25], and textile [26] industries, in biofuel production [27] and, perhaps
most importantly, in the construction of biosensors to measure blood glucose concentrations [28].
GOx variants with optimized kinetic parameters are valuable because they may increase the sensitivity
of glucose detection while boosting output power [25]. Several previous reports therefore describe
protein engineering and high-throughput screening methods to increase the activity [7,17,25] and
stability [6,29] of GOx.
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During the oxidation reaction, GOx reduces molecular oxygen to hydrogen peroxide, which
can in turn be used to measure GOx activity [30]. Accordingly, we adapted a previously reported
vanadium bromoperoxidase-coupled fluorescence assay (ViPer) for the detection of GOx activity and
developed an ultrahigh-throughput screening system based on droplet microfluidics to sort GOx gene
libraries and find variants with improved activity. Using this new system, we discovered a novel GOx
mutant with six point mutations conferring a 2.1-fold increase in the catalytic constant kcat compared
to wild-type GOx.
2. Results
The novel droplet microfluidics assay for GOx activity takes hydrogen peroxide produced by
GOx during the oxidation of glucose and uses it as a substrate for vanadium bromoperoxidase,
which combines hydrogen peroxide with bromide to produce hypobromite radicals. These radicals
are detected when they react with aminophenylfluorescein to produce fluorescein (Figure 1).
The accumulation of fluorescein in droplets containing a single yeast cell expressing a particular GOx
variant is easily detected by the optical system of the droplet sorter, with higher fluorescence intensity
correlated with higher GOx activity. Thresholds can be applied to sort droplets with high fluorescence
in real time, such that the cells with high-performing GOx variants are retained for further analysis.
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The use of vanadium bromoperoxidase rather than the more widely used HRP to couple the
detection of hydrogen peroxide to fluorescein production prevents a drop in fluorescence due to the
oxidation of fluorescent coumarin products by HRP in the presence of excess peroxide. Vanadium
bromoperoxidase does not contain a heme group and thus cannot oxidize phenolic substrates, which
ensures that vanadium bromoperoxidase assays achieve strong correlation between enzyme activity
and fluorescence [17].
An initial round of reference library sorting (using defined mixtures of cells expressing or not
expressing GOx) was required to determine the optimal laser position to ensure that the correct
droplet was captured by the sorting system each time a sorting burst was triggered. When the optimal
laser position was identified, a site-directed mutagenesis library of GOx sequences with mutations
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at 16 positions [6] (Table S1) was sorted several times to isolate droplets with the most intense
green fluorescence.
The library was created using consensus approach by multiple-site-directed mutagenesis at all
16 positions simultaneously (Figure 2) and contained 105 different GOx mutants among ~107 sorted
transformants. Recordings of the GOx library before and after sorting are shown in Figure 3.
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Figure 3. Analysis of glucose oxidase (GOx) library L1 using the new microfluidics system (upper
row) and on standard agar plates (lower row). The library was analyzed before sorting (BS), after the
first (S1), second (S2) and third (S3) rounds of sorting (S3). Red fluorescence (showing the number of
GOx molecules) reflects the detection of a C-terminal Myc epitope using a mouse primary anti-c-Myc
antibody and a secondary goat anti-mouse IgG antibody labeled with DyLight 550. The sorting gate in
the upper panels is between the green and pink lines.
Molecules 2020, 25, 2418 5 of 12
The retained variants were transferred to agar plates immediately after sorting, and colonies
derived from each sorted cell were tested for GOx activity using a standard 2,2′-azino-bis(3-
ethylbenzothiazoline-6-sulfonic acid) (ABTS) assay, in which GOx activity is revealed as a colored
halo surrounding the cells expressing an active GOx variant. This provided an initial readout for the
enrichment of each sorted library. We also conducted detailed kinetic analysis of the GOx variants
in microtiter plates in order to quantify the enzyme activity and classify the variants as inactive,
less active than wild-type GOx, or more active than wild-type GOx (Figure 4). After two rounds of
sorting, the proportion of cells in the population expressing GOx variants with higher than wild-type
activity exceeded 60% which compares favorably to the 36% obtained after sorting the same library
by flow cytometry [6]. After the third round of sorting under the same conditions, the proportion of
variants with higher than wild-type activity increased to 69%, and we could no longer detect any cells
expressing inactive GOx.
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activity, and more than wild-type activity before sorting (BS), and after the first (S1), second (S2) and
thir (S3) rounds of sorting.
The most active enzyme variants in the enrich d library were sequenced, recloned for expression
in Pichia pastoris, purified, and characterized in more detail (Table 1). The most active mutant in the
enriched library (A2) and three others (A21, F9 and F91) were also recover d by flow cytometr in our
previous study [6].
However, two new mutants (M6 and M15) were isolated for the first time in the current study.
M6 was the most active novel variant, and featured point mutations at six positions (Figure 5).
The catalytic constant of M6 was 2.1-fold higher than the wild-type enzyme and 1.4-fold higher
than its parent GOx variant (T30V, I94V and A162T).
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Table 1. Kinetic parameters of isolated mutants compared to wild-type glucose oxidase.
Enzyme Variant Km(mM)
kcat
(s−1)
kcat/Km
(mM−1·s−1) Sp (U/mg) Mutations
Wild Type 28.3 189 6.7 86.3
Parent 15.0 292 19.5 133 T30V, I94V, A162T
A2 18.5 498 26.9 227 T30V, I94V, A162T, R537K, M556V
A21 15.8 466 29.6 212 T30V, I94V, R537K, M556V
M6 18.2 401 22.0 183 T30V, R37K, I94V, A162T, A192T, M556V
F9 19.8 345 17.5 157 T30V, R37K, I94V, V106I, K152R, A162T, M556V
F91 15.1 276 18.3 126 T30V, R37K, I94V, V106I, K152R, A162T
M15 20.2 197 9.75 89.9 T30V, R37K, I94V, A162T, A192T, V293I, I507V, R537K
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3. Discussion
The sorting of gene libraries in a directed evolution experiment requires a physical connection
between the enzyme activity (phenotype) and the corresponding gene sequence (genotype).
The reactions must therefore be compartmentalized, and there must be no cross-talk between reaction
compartments caused by the diffusion of products. Furthermore, the reaction volume must be reduced
as far as possible to maximize the number of variants that can be screened in a short period of
time. These combined requirements led to the development of screening platforms based on yeast
surface display and in vitro compartmentalization. The enzyme reaction takes place inside water
microdroplets dispersed in an oil phase, which enables the rapid sorting of microdroplets by flow
cytometry. However, the diffusion of reaction products can lead to false positives, reducing the sorting
efficiency [7].
We developed the ViPer assay for GOx gene libraries in order to overcome some of the challenges
discussed above. The ViPer assay releases the charged fluorescent product carboxy-coumarin, hence
flow cytometry can be used to sort gene libraries in double emulsions prepared using light mineral
oil and ABIL EM90 detergent [17]. One drawback of this approach is the heterogeneity of the double
emulsion droplets, which means that fluorescence intensity can vary due to differences in compartment
size as well as enzyme activity. The screening results must therefore be normalized for different
reaction volumes in order to optimize the sorting efficiency, for example by tagging GOx expressed on
the surface of yeast cells with green fluorescent protein [31].
Microfluidics can address the issue of heterogeneity at source by generating monodisperse
microdroplets with little variance in reaction volume between reaction compartments, allowing the
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precise measurement of enzyme activity without normalization. We therefore adapted our ViPer assay
to make it compatible with a microfluidic system and the associated perfluorinated oils and detergent.
The flow of liquids in microchannels is highly sensitive to changes in liquid composition and LOC
manufacturing, so we optimized the laser deflection point to increase sorting efficiency. We then
tested the same GOx gene library previously sorted by flow cytometry [6] in order to compare the
sorting efficiencies of the two systems. After two rounds of sorting, we found that the proportion
of enzyme variants with higher than wild-type GOx activity increased from 6% to 36% when using
the original flow cytometry method, but from 2% to 61% using the new microfluidic system. In our
previous work, the proportion of active enzyme variants in an error-prone PCR GOx gene library after
two rounds of sorting by flow cytometry using the same ViPer assay was 28.12% [17], whereas using
our new microfluidic system increased the percentage of active enzyme variants to 97%. The new
microfluidics system outperformed flow cytometry due to the monodispersity of the emulsion and the
precise incubation time of the enzyme reaction. These results also suggest that fluorescein does not
diffuse through the fluorocarbon oil phase.
Although microfluidic systems clearly offer advantages for the directed evolution of enzymes, there
are few examples discussed in the literature. Fluorescence activated droplet sorting on microfluidic
devices has been used for the directed evolution of HRP [19] and esterase [32], but in both cases the aim
was to modify the specificity or enantioselectivity of the enzymes by comparing their activity against
different fluorogenic substrates. This facilitates the identification of superior variants because neither
the microdroplet volume nor the level of enzyme expression influences the ratio of two fluorescent
signals in the same compartment. Fluorescence-activated electrocoalescence has been used as part of
an in vitro translation system to sort a galactosidase reference library into positive droplets containing
active enzymes and negative droplets containing inactive variants [33]. Similarly, we previously used
a microfluidic system to sort a cellulase reference library into active and inactive variants [8]. In the
current study, the scale of the challenge was increased by using microfluidics to sort the most active
variants from a large background of mutants with lower but still measurable levels of enzyme activity.
Several challenges remain to be addressed before microfluidics can be used routinely for the
directed evolution of enzymes and protein engineering. Most fluorescence activated droplet sorting
systems are highly sensitive to the fluctuation of flow rates at device junctions caused by cell aggregates
or other debris, as well as the pulsatile nature of syringe pumps, although these engineering problems
can be solved prior to commercialization using current technology. Another drawback is that flow
cytometry can sort droplets into multiple channels, whereas microfluidics is restricted to binary
sorting. Like flow cytometry, most microfluidic devices rely on the detection of enzymatic activity
based on fluorescence, so a fluorogenic assay must be available for the enzyme of interest. However,
attempts to combine mass spectrometry-based detection with microfluidics for the directed evolution
of transaminase are promising, and this could enable the use of microfluidics for the directed evolution
of enzymes with phenotypes that cannot be coupled to fluorescent readouts [34].
In conclusion, we used a new microfluidics platform for GOx sorting to sort a library of cells
expressing variants of the enzyme GOx, and isolated those with higher than wild-type activity from
a large background of cells expressing active enzyme variants. The isolation of better-performing
enzyme variants was much more efficient using the microfluidics platform compared to our previous
flow cytometry method. We identified the novel GOx mutant M6, which was not previously isolated
by flow cytometry. This mutant contains six point mutations and its catalytic constant kcat is 2.1-fold
higher than wild-type GOx and 1.4-fold higher than the parent GOx variant. The microfluidic LOC
screening platform for GOx was therefore more sensitive than the flow cytometry system and can be
used for more comprehensive screens seeking active variants in GOx gene libraries containing multiple
mutations per gene.
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4. Materials and Methods
4.1. Multiple-Site-Directed Mutagenesis
The GOx saturation gene library was prepared using the QuickChange multiple-site-directed
mutagenesis kit (Agilent Technologies, Santa Clara, CA, USA). Primers were used to mutate 16 positions
in the GOx gene sequence (Table S1). The PCR mix contained 200 nM of the 16 primer mix and 400 pg/µL
of template DNA (GOx in vector pCTCON2). The reaction mix was heated to 95 ◦C for 1 min, followed
by 30 cycles of 95 ◦C for 1 min, 55 ◦C for 1 min and 65 ◦C for 16.5 min, and a final extension step at
65 ◦C for 20 min. The template DNA was then digested with DpnI for 3 h at 37 ◦C. The resulting
single-stranded plasmid DNA was introduced into E. coli XL10 Gold ultracompetent cells (Agilent
Technologies, Santa Clara, CA, USA) according to the manufacturer’s instructions. The library quality
and the introduced mutations were checked by sequencing randomly-selected clones.
4.2. Expression of GOx on the Surface of Yeast Cells
Saccharomyces cerevisiae EBY 100 cells (kindly provided by Prof. Dane Wittrup, MIT, Boston, MA,
USA) were transformed with plasmid DNA as previously described [35] by applying a 42 ◦C heat shock
for 2.5 h. The cells were transferred to YNB-CAA Glu medium for recovery, and were incubated at
27 ◦C, shaking at 160 rpm for 48 h. GOx expression was induced by transferring the cells to YNB-CAA
Gal/Raf medium and incubating as above for 16–18 h. Following induction, the cells were washed
three times with 50 mM Tris (pH 7.4) containing 0.01% Triton X-100 and were stained with mouse
anti-cMyc primary antibodies and with goat anti-mouse IgG DyLight 550 secondary antibodies as
previously described [6].
4.3. Fabrication of Microfluidic Devices
The polydimethylsiloxane microfluidic devices were prepared by soft lithography using SU8-on-Si
wafer masters and PDMS-on-glass devices as previously described [19]. Electrodes were made by
filling channels in the PDMS device with a low-melting-point alloy, by pushing the wire of Indalloy
19 (52 In, 32.5 Bi and 16.5 Sn) into punched holes. Electrical connections were made using eight-pin
terminal blocks (DigiKey, Thief River Falls, MN, USA) glued (Loctite, UV cured, Henkel, Disseldorf,
Germany) to the surface of the device.
4.4. Emulsification and Sorting
Monodisperse aqueous drops were prepared in fluorocarbon oil using a flow-focusing geometry
with three streams. The first stream was Novec HFE 7500 fluorocarbon oil (3M, St. Paul, MN, USA)
containing 1% (v/v) Krytox-PEG-Krytox detergent synthesized as previously described [36]. The second
stream was an aqueous solution containing a defined mixture of library cells (S. cerevisiae EBY100
cells) transformed with wild-type GOx (positive cells) or the empty pCTCON2 vector (negative cells).
The third stream was the aqueous substrate solution, consisting of 100 µM aminophenoxyfluorescein
(Invitrogen, Carlsbad, CA, USA) 200 mU/mL Corallina officinalis VBrPOx (Sigma-Aldrich, Taufkirchen,
Germany), 200 mM glucose, 10 mM NaBr and 1.5 mg/mL bovine serum albumin in 50 mM Tris-H2SO4
(pH 7.4).
Two aqueous streams were co-flowed to the droplet-making junction. Droplets 30 µm in diameter
were generated by directing the three streams (two aqueous and one oil stream) through a 10 µm
nozzle in order to produce droplets at a rate of 2 kHz with one encapsulated cell per three droplets.
The library cell and the substrate stream flow rate was 15 µL/h and the oil stream flow rate was 30 µL/h.
After emulsification, the droplets were passed through an incubation line (20 min) and reinjected into
the sorting device, where more oil was added to the droplet stream at a T-junction (flow rate = 400 µL/h)
to increase the inter-droplet spacing. The positive droplets were sorted at an asymmetric Y-junction by
measuring the fluorescence and sending several cycles of 20 kHz single-ended square waves to the
sorting electrodes using LabView software as previously described [19]. The droplets were sorted onto
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YNB-CAA Glu agar plates and the cells were recovered by incubation at 30 ◦C for 48 h. The process
was repeated several times to sort the entire library.
4.5. ABTS Assay in Agar Plates
Cells recovered on YNB-CAA Glu plates after droplet sorting were incubated at 27 ◦C for 72 h,
replica plated onto YNB-CAA Gal/Raf medium and incubated for an additional 24 h. The screening
medium was prepared by mixing a reaction solution containing 333 mM glucose, 1.75 U/mL HRP
and 7 mM ABTS with an equal volume of 2% agar. This medium was poured over the cells on the
YNB-CAA Gal/Raf plates. Green halos were observed around colonies showing GOx activity.
4.6. ABTS Assay in Microtiter Plates
Cells recovered on YNB-CAA Glu plates after droplet sorting were inoculated individually into the
wells of 96-well microtiter plates and were cultivated as previously described [37]. We then transferred
5 µL aliquots to new microtiter plates for the ABTS assay, as previously described [25,38,39] with some
modifications. The cell aliquots were resuspended in 70 µL phosphate-buffered saline and the OD600
was measured. We then added 70 µL 4 mM ABTS containing 1 U/mL HRP. Activity was measured by
spectrophotometry at 405 nm every 20 s for 10 min. Two measurements were taken from each culture,
both using 4 mM ABTS but containing either 250 or 5 mM glucose. For assay standardization, three
wild-type clones were included in each plate. Clones with less than 10% of the wild-type enzyme
activity were classed as inactive. The slope of the linear region was calculated for each reaction and
normalized to the OD600. The mutants showing the highest activity were selected and re-screened.
4.7. DNA Isolation and Recloning in P. Pastoris
Plasmid DNA was purified from the best-performing S. cerevisiae mutants as previously
described [40], the GOx genes were sequenced and then transferred to vector pICZalpha A (Invitrogen)
using XhoI/XbaI (New England Biolabs, Ipswich, MA, USA). Competent P. pastoris KM71H cells
(Invitrogen) were prepared and transformed as previously described [41], and the best-producing
clone representing each enzyme variant was selected.
4.8. Protein Purification
The transformed P. pastoris KM71H cells were cultivated by fermentation for 96 h following the
supplier’s recommendations. The cells were then pelleted by centrifugation (11,000× g, 10 min, room
temperature) using an Avanti J26 XP device (Beckman Coulter, Krefeld, Germany). The supernatant
containing GOx was passed through a 0.22 µm PTFE filter (Carl Roth, Karlsruhe, Germany) and
concentrated using a Viva Flow 50 system with a 10-kDa membrane (Sartorius, Goettingen, Germany)
to a final volume of 5–10 mL. The concentrated supernatant was than dialyzed against 10 mM
phosphate buffer pH 6.0 overnight at 4 ◦C, and loaded onto a 2 mL Fast Flow DEAE Sepharose column
(GE Healthcare Europe, Munich, Germany) using an ÄKTA purifier (GE Healthcare, Arlington Heights,
IL, USA). The protein was eluted in a linear gradient of 10–250 mM phosphate buffer (pH 6) over
30 column volumes. Collected 50 mL fractions were tested using the ABTS assay and those with
separate peaks of GOx activity were collected and concentrated to 5 mL using 10-kDa ultrafiltration
columns (Sartorius).
4.9. Kinetic Analysis
The kinetic parameters of each GOx variant were determined using triplicate ABTS assays in
microtiter plates with different glucose concentrations (1.2–266 mM) at pH 5.5 and 7.4. To determine the
Km and kcat values, the slope of each measurement was calculated over the linear region and fitted to a
Michaelis-Menten hyperbola using Origin v8 (OriginLab, Northampton, MA, USA). Lineweaver-Burk,
Eadie-Hofstee and Hanes-Woolf plots were also constructed, and the outliers were identified and
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removed. Protein concentration was determined by measuring the absorbance at 280 nm (the
absorption of 1.5 mg/mL GOx is considered equivalent to 1 AU based on the sequence, as calculated
using ProtParam).
Supplementary Materials: The following are available online. Table S1: Primers for consensus library; Co-flow
encapsulation device; Sorting device.
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